MONOCLONAL ANTIBODY SC104 AND DERIVATIVE THEREOF SPECIFICALLY BINDING TO A SIALYLTETRAOSYL CARBOHYDRATE AS A POTENTIAL ANTI-TUMOR THERAPEUTIC AGENT

摘要

The present invention provides an isolated specific binding member capable of binding a sialyltetraosyl carbohydrate and directly inducing cell death without the need for immune effector cells. Such a binding member may be an antibody or a part thereof. Also provided are the use of such binding members in medicine and nucleic acids encoding such binding members.